Complement inhibition at the level of C3 or C5: Mechanistic reasons for ongoing terminal pathway activity

Marco Mannes, Arthur Dopler, Oliver Zolk, Sophia J. Lang, Rebecca Halbgebauer, Britta Höchsmann, Arne Skerra, Christian K. Braun, Markus Huber-Lang, Hubert Schrezenmeier, Christoph Q. Schmidt

Research output: Contribution to journal › Article › peer-review

73 Scopus citations

Fingerprint

Dive into the research topics of 'Complement inhibition at the level of C3 or C5: Mechanistic reasons for ongoing terminal pathway activity'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology